EPB153	Starting antiretroviral therapy (ART) at the first HIV-specialist appointment with or without baseline laboratory data with BIC/FTC/TAF (The BIFAST study)	E-poster	ART in acute, first- and second-line therapies
EPLBB01	Standard versus double dose dolutegravir in patients with HIV-associated tuberculosis: a phase 2 non-comparative randomized controlled trial	E-poster	Tuberculosis: Prevention, diagnosis, treatment
PESUE22	Stakeholders' perspectives on the financial sustainability of HIV response in Nigeria	Poster exhibition	Approaches to achieving sustainability, including sustainable financing for civil society
EPA039	Spontaneous HIV control is associated with concentrations, and not the biophysical characteristics, of polyfunctional anti-Env specific antibody responses	E-poster	Immune mechanisms of natural or post-treatment control
EPC058	Spatio-temporal estimates of risk group proportions for adolescent girls and young women across 13 priority countries in sub-Saharan Africa	E-poster	Risk factors for acquisition, infectivity and transmission of HIV
EPE343	Sparking innovation with the integration of novel data visualization and geo-mapping tools into capacity building coaching sessions	E-poster	Innovative uses of data to strengthen systems and programmes
EPC291	South to south learning between Uganda and Kenya to scale up access to Medically Assisted Therapy services for people who inject drugs	E-poster	Access to harm reduction interventions
PEMOD65	South African adolescents living with HIV talk priorities! Longitudinal analysis of priorities of adolescent advisors living with HIV prior-to and during the COVID-19 pandemic	Poster exhibition	Social and behavioural aspects and approaches to COVID-19
EPF021	Solving the PrEP failure in the U.S.: a national PrEP financing and delivery program	E-poster	Laws and policies regulating access to drugs and medical devices (including intellectual property and trade regimes, competition law and price regulation)
PESAA13	Soluble interferon receptor (sIFNAR2) inhibits HIV-1 infection in macrophages through IFN-Î²-independent pathways	Poster exhibition	Innate immunity (including NK cells)